Closed loop with context-aware insulin delivery for type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests a smart insulin pump system that adjusts automatically during exercise. It aims to make managing blood sugar easier and safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had type 1 diabetes for at least 1 year.
- You must be 18 years or older and currently using an approved hybrid closed loop system (like a Medtronic 670G, Tandem t:slim with Control-IQ, or Omnipod 5) for at least 3 months.
- Your most recent HbA1c or GMI (a measure of blood sugar control) must be between 6.5% and 10.5%.
- You must live with another adult who can sleep in the house at night and attend a training session.
- You must live within 40 miles of Oregon Health & Science University in Portland, Oregon.
- You must be physically able to do 30 minutes of exercise and not have any serious heart, kidney, or liver problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study tests an “artificial pancreas” system that automatically helps control insulin to reduce wide swings in blood sugar. It also aims to see whether steadier sugars can improve heart health in adults with type 1 diabetes.
This study tests how well the Tandem Mobi insulin pump and Dexcom continuous glucose monitor work for young competitive athletes with type 1 diabetes. If you join, you'll use this system during your regular training and competition to see how safe and easy it is.
This trial is testing a closed-loop system that automatically adjusts insulin delivery to keep blood sugar in a healthy range, in a simulated hospital setting. If you have type 1 or type 2 diabetes and use insulin, this could help you manage your glucose more effectively.
This study tests an automated insulin pump system that adjusts insulin delivery to help keep blood sugar levels stable during pregnancy. It may reduce the burden of managing type 1 diabetes and improve outcomes for you and your baby.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.